Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy-Reference-Cited by-同舟云学术

Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy

Published:2018-05-17 Issue:1 Volume:39 Page:40-69
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med Res Rev

Author:

Wüstemann Till¹,Haberkorn Uwe¹²,Babich John³,Mier Walter¹^ORCID

Affiliation:

1. Department for Nuclear Medicine; Heidelberg University Hospital; Heidelberg Germany

2. German Cancer Consortium (DKTK); Heidelberg Germany

3. Department for Radiology; Weill Cornell Medicine; New York NY USA

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/med.21508/fullpdf

Reference177 articles.

1. Cancer of the prostate: eSMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(aEuro);Parker;Ann Oncol,2015

2. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

3. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: Treatment of relapsing, metastatic, and castration-resistant prostate cancer;Cornford;Eur. Urol,2017

4. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients;Horoszewicz;Anticancer Res,1987

5. PET/CT with 68Ga-PSMA in prostate cancer: Radiopharmaceutical background and clinical implications;Giovacchini;Curr Radiopharm,2017

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Searching for Protein Off-Targets of Prostate-Specific Membrane Antigen-Targeting Radioligands in the Salivary Glands;Cancer Biotherapy and Radiopharmaceuticals;2024-09-13

2. Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen;Nuclear Medicine and Biology;2024-09

3. Nanotherapy to Reshape the Tumor Microenvironment: A New Strategy for Prostate Cancer Treatment;ACS Omega;2024-06-12

4. Diagnostic Positron Emission Tomography Imaging with Zirconium-89 Desferrioxamine B Squaramide: From Bench to Bedside;Accounts of Chemical Research;2024-04-26

5. PSMAx-Guided PROTAC Degraders for Tumor-Specific Protein Degradation in Prostate Cancer;2024-04-26